Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
12/07/201714h00GlobeNewswire Inc.Insmed to Host Analyst and Investor Day on July 19, 2017NASDAQ:INSMInsmed Inc
13/06/201714h00GlobeNewswire Inc.Insmed to Present at the JMP Securities Life Sciences ConferenceNASDAQ:INSMInsmed Inc
12/06/201722h09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
08/06/201714h00GlobeNewswire Inc.Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
07/06/201722h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
07/06/201722h07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
22/05/201722h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
19/05/201722h28Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:INSMInsmed Inc
15/05/201713h00GlobeNewswire Inc.Insmed Announces Key Additions to its Executive Management TeamNASDAQ:INSMInsmed Inc
03/05/201714h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
03/05/201714h02GlobeNewswire Inc.Insmed Reports First Quarter 2017 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
27/04/201713h00GlobeNewswire Inc.Insmed to Present at the Deutsche Bank 42nd Annual Health Care ConferenceNASDAQ:INSMInsmed Inc
26/04/201713h00GlobeNewswire Inc.Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017NASDAQ:INSMInsmed Inc
07/04/201722h21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
07/04/201722h19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
16/03/201716h46Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INSMInsmed Inc
28/02/201714h00GlobeNewswire Inc.Insmed to Present at the Cowen and Company 37th Annual Health Care ConferenceNASDAQ:INSMInsmed Inc
23/02/201714h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
23/02/201714h02GlobeNewswire Inc.Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
16/02/201713h00GlobeNewswire Inc.Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017NASDAQ:INSMInsmed Inc
14/02/201717h29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
14/02/201714h05GlobeNewswire Inc.Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. PatentNASDAQ:INSMInsmed Inc
04/01/201714h00GlobeNewswire Inc.Insmed to Present at the 35th Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
14/11/201614h00GlobeNewswire Inc.Insmed to Participate at November Investor ConferencesNASDAQ:INSMInsmed Inc
04/11/201620h05Business WireRobbins Arroyo LLP Is Investigating the Officers and Directors of Insmed, Inc. (INSM) on Behalf of ShareholdersNASDAQ:INSMInsmed Inc
03/11/201613h02GlobeNewswire Inc.Insmed Reports Third Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
27/10/201614h00GlobeNewswire Inc.Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016NASDAQ:INSMInsmed Inc
18/10/201614h00GlobeNewswire Inc.Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung DiseaseNASDAQ:INSMInsmed Inc
05/10/201612h55GlobeNewswire Inc.Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 InhibitorNASDAQ:INSMInsmed Inc
27/09/201614h00GlobeNewswire Inc.Insmed Appoints Roger Adsett as Chief Commercial OfficerNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM